Potential health gains for patients with metastatic renal cell carcinoma in daily clinical practice: A real-world cost-effectiveness analysis of sequential first- and second-line t...

Por De Groot, S., Blommestein, H. M., Redekop, W. K., Sleijfer, S., Kiemeney, L. A. L. M., Oosterwijk, E., Uyl-de Groot, C. A.
Publicado no PLoS One (2017)